Dementia Flashcards

1
Q

What are the various types of dementia and frequencies?

A
  • Alzheimer’s 60-80% (May be up to 85%)
  • Lewy Body Dementia 5-10%
  • Vascular Dementia 5-10%
  • Frontotemporal Dementia 5-10%
  • Others: Parkinson’s, Huntington’s

*May have mixed dementias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are possible etiologies of memory loss?

A
  • Neurodegenerative causes

- Secondary causes: depression, medications (anticholinergic side effects), multiple comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is mild cognitive impairment?

A

Not part of normal aging

-Deficit in 1 of 4 areas of cognition (language, spacial ability, learning/memory, executive control)

  • S/S: memory complaints, abnormal memory for age, no functional disability, normal general cognitive function
  • Increases risk for developing AD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some examples of cognitive Impairment screening tools?

A
-Mini-Mental Status Exam (MMSE): Standardized, well-studied, tracks progress and decline, quantifies cognitive function
30 Components
Scoring: 
22-24: Mild
15-21: Moderate
<15: Severe 

Mini-Cog:
Uncued 3-item recall test with clock-drawing test (CDT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What follow-up is required for positive screens for cognitive impairment?

A

Refer for neurological evaluation
Refer for neuropsychological evaluation
Diagnostic imaging and labs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What would signify a non-AD dementia diagnosis?

A
  • Rapid onset
  • Rapid progression
  • Non-memory presentation
  • Onset <50yo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lewy Body Dementia

Characteristics

A

-Late-onset (75-80yo)
-Fluctuating cognitive impairment, recurrent visual hallucinations, parkinsonism, depression
Duration: 6 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dementia
Diagnostic Tests
Imaging and Labs

A

Structural neuroimaging: non-contrast CT or MRI

Screen for depression, B12 deficiency, hypothyroidism

Genetic markers not approvied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Alzheimer’s Disease

Characteristics

A
  • Progressive, neurodegenerative disorder
  • Average life span following diagnosis depends on age at dx, typically 7-10 years
  • Amnesia, aphasia, apraxia, agnosia
  • Difficulty with memory, recall, language, psychomotor function.
  • Personality changes, irritability, hallucinations, agitation
  • Incontinence, dysphagia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alzheimer’s Disease

Etiology

A

Etiology unknown:

Amyloid Hypothesis: Abnormal processing of amyloid precursor protein (APP), increases in beta-amyloid creates plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alzheimer’s Disease

Risk Factors

A
  • Cardiovascular disease: heart disease
  • Increased homocysteine levels
  • APOE-e4 (cholesterol carrying protein) susceptibility gene for AD, affects age of onset of disease
  • Aging
  • Genetics
  • Female gender
  • Possibly depression
  • Possible hypothyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Screening for Depression in Older Adults with dementia considerations

A

Screen older adults using

  • Single question
  • Geriatric depression scale (GDS)
  • Cornell Depression in Dementia Scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the BEERS list?

A
  • Meds to avoid in patients >65yo
  • Anticholinergics
  • Some may induce dementia like symptoms - decreased cognitive function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vascular Dementia

Criteria/Characteristics

A
  • Evidence of 2 or more strokes by history, neurologic signs, or imaging or single stroke with a clear temporal relationship to onset of dementia
  • Evidence of at least 1 infarct outside the cerebellum by CT or T1-weighted MRI

Silent brain infarcts increase risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neuropsychological testing for dementia/cognitive impairment

A
  • Aphasia: Ability to understand or express speech
  • Agnosia: Ability to interpret sensations and recognize things. Spacial abilities, change in visual perception
  • Learning and memory: MMSE, Recall
  • Executive function: ability to organize, attention, concentration

Apraxia: Ability to act our intentions psychomotor speed, seen later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alzheimer’s Disease
Diagnosis
Imaging and Labs

A
  • Rule out other causes. CT (brain injury, tumor, stroke), MRI (cerebral atrophy)
  • MRI without contrast typical for diagnosis

PET scans more detailed, hard to get approved by insurance (FDG or Amyloid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Amyloid PET Scan

AD

A
  • Measures beta-amyloid deposits.

- High levels of beta-amyloid are associated with beta-amyloid plaques.

18
Q

Tau PET Scan

AD

A

Identifies abnormal distribution of tau/Neurofibrillary Tangles (NFTs)

19
Q

FDG PET Scan

AD

A

Visualization of glucose uptake in brain

Can be abnormal in certain areas with AD

20
Q

Alzheimer’s Disease

Pharmacological Management

A
  • Cholinesterase inhibitors (AChEIs)
  • NMDA-receptor antagonists
  • Disease modifying therapies (DMTs)
  • Immunizations on the horizon
  • Atypical antipsychotics
  • SSRIs
21
Q
Cholinesterase inhibitors (AChEIs)
Indications/Considerations
A
  • Tx of mild, mod, severe AD dementia
  • Prevents AChE from breaking down into acetylcholine
  • Slows progression
  • May improve functional performance, slow rate of cog and behavioral decline
  • Cannot stop med, patient will decline
  • May d/c if side effects do not resolve, n/v/d, vivid dreams (try to take in AM), poor adherence to tx, hospice care
22
Q
Cholinesterase inhibitors (AChEIs)
Examples
A
  • donepezil (Aricept)
  • rivastigmine (Exelon)
  • galantamine (Razadyne ER, Razadyne)
23
Q

NMDA-receptor antagonist

Examples

A

-memantine (Namenda)

24
Q

NMDA-receptor antagonist

Indications/Considerations

A
  • Increased amount of glutamate available in the brain in AD
  • Glutamate major neuroexcitatory neurotransmitter
  • Blocks glutamate from accessing NMDA receptors, preventing excessive calcium from entering cells and causing damage.
  • Slows progression
  • Mod to severe dementia
  • Continue for life
25
Q

Dementia -

Primary care management

A
  • Lifestyle changes: Nutrition, exercise, cognitive training, social activity
  • Intensive monitoring and management of metabolic and vascular risk
  • Regular assessment/reassessment of cognitive status, caregiver burden, stage-based approach, encourage structured environment, refer to community resources
26
Q

Mild cognitive impairment -

Primary care management

A
  • Fitness for driving: MMSE >24 fitness for driving, refer for handicap driving evaluation if borderline
  • Depression screening
  • Monitor functional and cognitive status
  • Safety screen: firearms, caregiver, home setup
  • Advance Care Planning
27
Q

Early Stage Dementia -

Primary care management

A
  • Depression screen
  • Fitness for driving
  • Safety screen
  • Monitor functional and cognitive status
  • Advance Care Planning
  • Caregiver burden
28
Q

Moderate to Severe Dementia

Primary Care Management

A
  • Behavioral and psychological symptoms of dementia (BPSD): sleep-cycle, sun-downing, wandering, unsafe behaviors
  • Dysphagia
  • Caregiver burden
29
Q

Dementia

Education/HP

A
  • AD not normal part of aging
  • Progressive brain disease
  • Cannot predict prognosis, varies greatly
  • Medications may slow progression or manage symptoms, no cure
30
Q

Role of Ginkgo Biloba in dementia treatment?

A

Do not recommend. No measurable benefit.

31
Q

Parkinson’s Disease

Characteristics

A
  • Akinetic movement disorder
  • Associated with basal ganglia dysfunction, Lewy bodies, and degeneration of the substantia nigral dopaminergic neurons
  • S/S: Depression, anxiety, hallucinations, apathy
32
Q

BEERs List

Anticholinergics

A

Anticholinergics:

  • First Gen Antihistamines
  • Antiparkinsonian Agents
  • Antispasmodics
33
Q

BEERS List

Antithrombotics

A

-dipyridamole

34
Q

BEERS List

Anti-infective

A

-Nitrofurantoin

35
Q

BEERS list

CV

A

-Peripheral alpha-1 blockers (doxazosin, prazosin, terasozin)

Central alpha-agonists (clonidine as first-line)

  • Dysopyramidde
  • Dronedarone
  • Digoxin (as first-line)
  • Nifedipine (hypotension)
  • Amiodarone (as first-line)
36
Q

BEERS List

CNS Agents

A

Antidepressants
-TCA, MAOIs (highly anticholinergic)

Antipsychotics

Barbiturates

Benzos

Meprobamate

Z-Drugs: Hypnotics

37
Q

BEERS List

Endocrine Agents

A
  • Androgens
  • Desiccated thyroid
  • Estrogens w/o progesterone
  • Growth hormone
  • Insulin, short or rapid
  • Megestrol
  • Sulfonylureas
38
Q

BEERS List

GI Agents

A
  • Metoclopramide (EPS SEs)
  • Mineral oil
  • PPIs (C. diff risk, bone loss, fractures)
39
Q

BEERS List

Pain Meds

A
  • Meperidine (delirium)
  • Non-cyclooxygenase-selective NSAIDs (aspirin, ketoprofen, ibuprofen, naproxen - r/f ulcers, bleeding, CV risk)
  • Indomethacin, ketorolac (bleeding, ulcer)
  • Skeletal muscle relaxants
40
Q

BEERS List

GU

A

Desmopressin (hyponatremia)